[1] Jackson DW,Simon TM,Aberman HM. Symptomatic articular cartilage degeneration:the impact in the new millennium[J].Clin Orthop Relat Res,2001(391 Suppl):S14－ S25.
[2] Gomoll AH,Farr J,Gillogly SD,et al. Surgical management of articular cartilage defects of the knee[J]. Instr Course Lect,2011,60:461－483.
[3] Cucchiarini M,Madry H. Gene therapy for cartilage defects[J]. J Gene Med,2005,7(12):1495－1509.
[4] Buckwalter JA,Mankin HJ. Articular cartilage:tissue design and hondrocyte-matrix interactions[J]. Instr Course Lect,1998,47:477－486.
[5] Kaul G,Cucchiarini M,Arntzen D,et al. Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo[J]. J Gene Med,2006,8(1):100－111.
[6] Madry H,Kaul G,Cucchiarini M,et al. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor Ⅰ(IGF-Ⅰ)[J]. Gene Ther,2005,12(15):1171－1179.
[7] Madry H,Emkey G,Zurakowski D,et al. Overexpression of human fibroblast growth factor 2 stimulates cell proliferation in an ex vivo model of articular chondrocyte transplantation[J]. J Gene Med,2004,6(2):238－245.
[8] Tsuchiya H,Kitoh H,Sugiura F,et al. Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells[J]. Biochem Biophys Res Commun,2003,301(2):338－343.
[9] Grossin L,Cournil-Henrionnet C,Pinzano A,et al. Gene transfer with HSP 70 in rat chondrocytes confers cytoprotection in vitro and during experimental osteoarthritis[J]. FASEB J,2006,20(1):65－75.
[10] Zhang HN,Leng P,Wang YZ,et al. Treating human meniscal fibrochondrocytes with hIGF-1 gene by liposome[J]. Clin Orthop Relat Res,2009,467(12):3175－3182.
[11] Manning K,Rachakonda PS,Rai MF,et al. Co-expression of insulin-like growth factor-1 and interleukin-4 inan in vitro inflammatory model[J]. Cytokine,2010,50(3):297－305.
[12] Madry H,Zurakowski D,Trippel SB. Overexpression of human insulin-like growth factor-Ⅰ promotes new tissue formation in an ex vivo model of articular chondrocyte transplantation[J]. Gene Ther,2001,8(19):1443－1449.
[13] Li Y,Tew SR,Russell AM,et al. Transduction of passaged human articular chondrocytes with adenoviral,retroviral,and lentiviral vectors and the effects of enhanced expression of SOX9[J].Tissue Eng,2004,10(3/4):575－584.
[14] Brower-Toland BD,Saxer RA,Goodrich LR,et al. Direct adenovirus-mediated insulin-like growth factor Ⅰ gene transfer enhances transplant chondrocyte function[J]. Hum Gene Ther,2001,12(2):117－129.
[15] Gelse K,Jiang QJ,Aigner T,et al. Fibroblast-mediated delivery of growth factor complementary DNA into mouse joints induces chondrogenesis but avoids the disadvantages of direct viral gene transfer[J]. Arthritis Rheum,2001,44(8):1943－1953.
[16] Musgrave DS,Pruchnic R,Bosch P,et al. Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2[J]. J Bone Joint Surg Br,2002,84(1):120－127.
[17] Ikeda T,Kamekura S,Mabuchi A,et al. The combination of SOX5,SOX6,and SOX9 (the SOX trio ) provides signals sufficient for induction of permanent cartilage[J]. Arthritis Rheum,2004,50(11):3561－3573.
[18] Haupt JL,Frisbie DD,McIlwraith CW,et al. Dual transduction of insulin-like growth factor-Ⅰ and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model[J]. J Orthop Res,2005,23(1):118－126.
[19] Steinert AF,Palmer GD,Capito R,et al. Genetically enhanced engineering of meniscus tissue using ex vivo delivery of transforming growth factor- 1 complementary deoxyribonucleic acid[J]. Tissue Eng,2007,13(9):2227－2237.
[20] Steinert AF,Proffen B,Kunz M,et al. Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bonemor phogenetic protein-2 and bone morphogenetic protein-4 gene transfer[J]. Arthritis Res Ther,2009,11(5):R148.
[21] Mason JM,Breitbart AS,Barcia M,et al. Cartilage and bone regeneration using gene-enhanced tissue engineering[J]. Clin Orthop Relat Res,2000(379 Suppl):S171－ S178.
[22] Goto H,Shuler FD,Niyibizi C,et al. Gene therapy for meniscal injury: enhanced synthesis of proteoglycan and collagen by meniscal cells transduced with a TGFbeta ( 1 ) gene [J].Osteoarthritis Cartilage,2000,8(4):266－271.
[23] Tew SR,Li Y,Pothacharoen P,et al. Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes [J].Osteoarthritis Cartilage,2005,13(1):80－89.
[24] Pagnotto MR,Wang Z,Karpie JC,et al. Adeno-associated viral gene transfer of transforming growth factor-beta1 to human mesenchymal stem cells improves cartilage repair[J]. Gene Ther,2007,14(10):804－813.
[25] Cucchiarini M,Thurn T,Weimer A,et al. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9[J]. Arthritis Rheum,2007,56(1):158－167.
[26] Cucchiarini M,Terwilliger EF,Kohn D,et al. Remodelling of human osteoarthritic cartilage by FGF-2,alone or combined with Sox9 via rAAV gene transfer[J]. J Cell Mol Med,2009,13(8B):2476－2488.
[27] Chamberlain JR,Schwarze U,Wang PR,et al. Gene targeting in stem cells from individuals with osteogenesis imperfecta[J].Science,2004,303(5661):1198－1201.
[28] Basile P,Dadali T,Jacobson J,et al. Freeze-dried tendon allografts as tissue-engineering scaffolds for Gdf5 gene delivery [J]. Mol Ther,2008,16(3):466－473.
[29] Ito H,Koefoed M,Tiyapatanaputi P,et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy[J]. Nat Med,2005,11(3):291－297.
[30] Wang XT,Liu PY,Xin KQ,et al. Tendon healing in vitro:bFGF gene transfer to tenocytes by adeno-associated viral vectors promotes expression of collagen genes[J]. J Hand Surg Am,2005,30(6):1255－1261.
[31] Tang JB,Cao Y,Zhu B,et al. Adeno-associated virus-2-mediated bFGF gene transfer to digital flexor tendons significantly increases healing strength. an in vivo study[J]. J Bone Joint Surg Am,2008,90(5):1078－1089.
[32] Cucchiarini M,Schetting S,Terwilliger EF,et al. rAAV mediated overexpression of FGF-2 promotes cell proliferation,survival,and alpha-SMA expression in human meniscal lesions[J]. Gene Ther,2009,16(11):1363－1372.
[33] Xiao X,Li J,Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector[J]. J Virol,1996,70(11):8098－8108.
[34] Kafienah W,Al-Fayez F,Hollander AP,et al. Inhibition of cartilage degradation: a combined tissue engineering and gene therapy approach[J]. Arthritis Rheum,2003,48(3):709－718.
[35] Baragi VM,Renkiewicz RR,Jordan H,et al. Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation[J]. J Clin Invest,1995,96(5):2454－2460.
[36] Kim SH,Kim S,Evans CH,et al. Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4[J]. J Immunol,2001,166(5):3499－3505.
[37] Schmal H,Mehlhorn AT,Zwingmann J,et al. Stimulation of chondrocytes in vitro by gene transfer with plasmids coding for epidermal growth factor(hEGF) and basic fibroblast growth factor (bFGF)[J]. Cytotherapy,2005,7(3):292－300.
[38] Lee DK,Choi KB,Oh IS,et al. Continuous transforming growth factor beta1 secretion by cell-mediated gene therapy maintains chondrocyte redifferentiation[J]. Tissue Eng,2005,11(1/2):310－318.
[39] Surendran S,Kim SH,Jee BK,et al. Anti-apoptotic Bcl-2 gene transfection of human articular chondrocytes protects against nitric oxide-induced apoptosis[J]. J Bone Joint Surg Br,2006,88(12):1660－1665.
[40] Piera-Velazquez S,Jimenez SA,Stokes D. Increased life span of human osteoarthritic chondrocytes by exogenous expression of telomerase[J]. Arthritis Rheum,2002,46(3):683－693.
[41] Doherty PJ,Zhang H,Tremblay L,et al. Resurfacing of articular cartilage explants with genetically modified human chondrocytes in vitro[J]. Osteoarthritis Cartilage,1998,6(3):153－159.
[42] Hidaka C,Quitoriano M,Warren RF,et al. Enhanced matrix synthesis and in vitro formation of cartilage-like tissue by genetically modified chondrocytes expressing BMP-7 [J]. J Orthop Res,2001,19(5):751－758.
[43] Eming SA,Snow RG,Yarmush ML,et al. Targeted expression of insulin-like growth factor to human keratinocytes:modification of the autocrine control of keratinocyte proliferation[J]. J Invest Dermatol,1996,107(1):113－120.
[44] Patel RS,Temu TM,Jeanbart L,et al. A localizable,biological-based system for the delivery of bioactive IGF-1 utilizing microencapsulated genetically modified human fibroblasts[J].ASAIO J,2009,55(3):259－265.
[45] Park J,Gelse K,Frank S,et al. Transgene-activated mesenchymal cells for articular cartilage repair:a comparison of primary bone marrow-,perichondrium /periosteum-and fat-derived cells[J]. J Gene Med,2006,8(1):112－125.
[46] Che JH,Zhang ZR,Li GZ,et al. Application of tissue-engineered cartilage with BMP-7 gene to repair knee joint cartilage injury in rabbits[J]. Knee Surg Sports Traumatol Arthrosc,2010,18(4): 496－503.
[47] Gelse K,Muhle C,Franke O,et al. Cell based resurfacing of large cartilage defects:long-term evaluation of grafts from autologous transgene-activated periosteal cells in a porcine model of osteoarthritis[J]. Arthritis Rheum,2008,58(2):475－488.
[48] Vogt S,Wexel G,Tischer T,et al. The influence of the stable expression of BMP2 in fibrinclots on the remodelling and repair of osteochondral defects[J]. Biomaterials,2009,30(12):2385－2392.
[49] Guo X,Zheng Q,Yang S,et al. Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor beta1 gene[J]. Biomed Mater,2006,1(4):206－215.
[50] Katayama R,Wakitani S,Tsumaki N,et al. Repair of articular cartilage defects in rabbits using CDMP1 gene-transfected autologous mesenchymal cells derived from bone marrow[J]. Rheumatology(Oxford),2004,43(8):980－985.
[51] Evans CH,Robbins PD,Ghivizzani SC,et al. Gene transfer to human joints:progress toward a gene therapy of arthritis[J]. Proc Natl Acad Sci U S A,2005,102(24):8698－8703.
[52] Brittberg M. Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix induced autologous chondrocyte implantation procedure[J]. Am J Sports Med,2010, 38(6):1259－1271.
[53] Tuan RS. Stemming cartilage degeneration: adult mesenchymal stem cells as a cell source for articular cartilage tissue engineering[J]. Arthritis Rheum,2006,54(10):3075－3078.
[54] Loken S,Jakobsen RB,Aroen A,et al. Bone marrow mesenchymal stem cells in a hyaluronan scaffold for treatment of an osteochondral defect in a rabbit model[J]. Knee Surg Sports Traumatol Arthrosc,2008,16(10):896－903.